Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | HCID 66824634 | HCID 66824634 | — |
| Product | HCID 66824465 | HCID 66824465 | 84% |
Reaction Steps
2-amino-6-hydrazino-9-(2-hydroxyethyl)-7-methyl-purin-8-one (4.5 g, 18.18 mmol) obtained in step 4,2-furoic acid (2.53 g, 22.5 mmol), HOBT (2.53 g, 18.8 mmol) and N-methylmorpholine were taken in dimethylformamide (40 ml). 1-Ethyl-3(3′-dimethylaminopropryl)carbodiimide hydrochloride (EDCI.HCl) (5.4 g, 28.2 mmol) was added to the reaction mixture and stirred at 25-27° C. for 14 hours. The reaction mixture was evaporated and residue was purified by column chromatography to obtain N′-[2-amino-9-(2-hydroxyethyl)-7-methyl-8-oxo-purin-6-yl]furan-2-carbohydrazide (5.3 g, 84%) as an off white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09006177B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-235d9a0d252a49bca9a4003a70dede86 |
|---|
| Source note | uspto-grants-2015_04 |
|---|